Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › West Bloomfield › NPI 1578048096
Supplier

Wellstreet Urgent Care of Michigan

Wellstreet Urgent Care of Michigan was paid $37.45M by Medicaid between Feb 2019 and Dec 2024, across 83 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.

33Billing provider infoWELLSTREET URGENT CARE OF MICHIGAN
WEST BLOOMFIELD, MI 48322
33aNPI1578048096assigned 10/01/2018
28Total paid$37.45M
24GClaims690,502
24DCodes billed83
24AFirst – last monthFeb 2019 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201925,514$1.01M
202076,359$2.97M
2021148,015$7.61M
2022162,352$9.90M
2023152,413$8.98M
2024incomplete125,849$6.98M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 23% 110,972 104,419 $8.72M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 22% 83,227 80,076 $8.37M
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 19% 89,975 89,464 $7.15M
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 14% 44,018 43,799 $5.22M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 6.1% 54,294 51,250 $2.30M
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3.2% 43,806 41,949 $1.19M
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 1.7% 4,774 4,727 $627K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.4% 31,557 24,267 $512K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 1.3% 9,645 9,596 $469K
99205 Prolong outpt/office vis 1.2% 3,012 3,001 $457K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 31,976 31,501 $371K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 4,569 4,411 $249K
71 more codes
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 21,660 $181K
81025 <1% 27,121 $168K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 4,923 $144K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 3,238 $132K
71046 Radiologic examination, chest; 2 views <1% 7,136 $117K
93000 <1% 7,787 $101K
73130 <1% 4,609 $91K
81003 <1% 38,892 $88K
73630 <1% 4,655 $83K
73610 <1% 3,768 $74K
73564 <1% 2,481 $58K
12001 <1% 967 $58K
73110 <1% 2,136 $46K
90715 <1% 1,481 $43K
S9083 Global fee urgent care centers <1% 4,179 $41K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,521 $40K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,225 $35K
69210 <1% 908 $33K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 3,811 $32K
10060 <1% 301 $23K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,968 $22K
73030 <1% 1,215 $21K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,641 $21K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,388 $19K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,794 $18K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 1,651 $14K
71101 <1% 625 $13K
73080 <1% 521 $9K
87807 <1% 640 $7K
72100 <1% 351 $7K
87631 <1% 70 $7K
E0114 Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips <1% 254 $6K
82962 <1% 2,001 $5K
86308 <1% 1,355 $5K
73590 <1% 274 $4K
L3908 Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf <1% 115 $4K
74019 <1% 167 $3K
L1902 Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf <1% 84 $3K
L3809 Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type <1% 29 $3K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 486 $3K
73090 <1% 191 $3K
73502 <1% 106 $3K
69209 <1% 180 $3K
26010 <1% 12 $2K
A6449 Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard <1% 1,390 $2K
29125 <1% 54 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 91 $2K
L4361 Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf <1% 12 $2K
29130 <1% 82 $2K
12002 <1% 25 $2K
90714 <1% 67 $2K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 1,146 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 271 $1K
L3260 Surgical boot/shoe, each <1% 99 $1K
87905 <1% 98 $725.64
84703 <1% 94 $645.73
Q4049 Finger splint, static <1% 300 $554.54
29515 <1% 12 $471.12
99201 <1% 17 $458.25
A4565 Slings <1% 132 $409.26
90674 <1% 17 $350.76
90688 <1% 16 $299.68
74018 <1% 12 $259.63
Q4022 Cast supplies, short arm splint, adult (11 years +), fiberglass <1% 12 $108.27
99421 <1% 27 $75.00
36415 Collection of venous blood by venipuncture <1% 26 $70.20
82948 <1% 13 $41.80
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 26 $41.36
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 293 $35.17
81002 <1% 14 $25.92
99051 0% 414 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRESNICK, LEE (CHIEF MEDICAL OFFICER)